Philipp Zelger, Benjamin Jenewein, Magdalena Sovago, Felix J Krendl, Andras T Meszaros, Benno Cardini, Philipp Gehwolf, Johannes D Pallua, Simone Graf, Stefan Schneeberger, Margot Fodor, Rupert Oberhuber
{"title":"常温肝机灌注时肝外胆管的频谱分析。","authors":"Philipp Zelger, Benjamin Jenewein, Magdalena Sovago, Felix J Krendl, Andras T Meszaros, Benno Cardini, Philipp Gehwolf, Johannes D Pallua, Simone Graf, Stefan Schneeberger, Margot Fodor, Rupert Oberhuber","doi":"10.3390/bioengineering12090966","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background</b>: Biliary complications (BC) affect 5-32% of liver transplant (LT) patients and include strictures, leaks, stones, and disease recurrence. Their risk increases with extended criteria donor (ECD) livers, contributing to early graft dysfunction. Normothermic liver machine perfusion (NLMP) helps reduce bile duct (BD) damage overall, but anastomotic region issues persist. This study assessed hyperspectral imaging (HSI) as a non-invasive method to evaluate BD viability during NLMP. <b>Methods</b>: Eleven donor livers underwent NLMP with HSI at the start and end. Seven were transplanted; four were discarded. HSI measured tissue oxygenation, perfusion, and composition. The spectral data were analyzed using ANOVA, post hoc t-tests, and multifactorial ANOVA to assess spectral changes related to BD position, transplant status, and occurrence of BC. <b>Results</b>: Significant spectral changes were found in the BD region during NLMP. Transplanted livers that developed BC showed changes between 525 and 850 nm, while discarded ones had changes between 625 and 725 nm. Specific spectral bands (500-575 nm, 775-1000 nm) were linked to transplant outcomes and BC. <b>Conclusions:</b> HSI shows promise as a non-invasive tool to assess BD viability during NLMP and may help predict post-transplant BC.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 9","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12467302/pdf/","citationCount":"0","resultStr":"{\"title\":\"Spectral Analysis of Extrahepatic Bile Ducts During Normothermic Liver Machine Perfusion.\",\"authors\":\"Philipp Zelger, Benjamin Jenewein, Magdalena Sovago, Felix J Krendl, Andras T Meszaros, Benno Cardini, Philipp Gehwolf, Johannes D Pallua, Simone Graf, Stefan Schneeberger, Margot Fodor, Rupert Oberhuber\",\"doi\":\"10.3390/bioengineering12090966\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background</b>: Biliary complications (BC) affect 5-32% of liver transplant (LT) patients and include strictures, leaks, stones, and disease recurrence. Their risk increases with extended criteria donor (ECD) livers, contributing to early graft dysfunction. Normothermic liver machine perfusion (NLMP) helps reduce bile duct (BD) damage overall, but anastomotic region issues persist. This study assessed hyperspectral imaging (HSI) as a non-invasive method to evaluate BD viability during NLMP. <b>Methods</b>: Eleven donor livers underwent NLMP with HSI at the start and end. Seven were transplanted; four were discarded. HSI measured tissue oxygenation, perfusion, and composition. The spectral data were analyzed using ANOVA, post hoc t-tests, and multifactorial ANOVA to assess spectral changes related to BD position, transplant status, and occurrence of BC. <b>Results</b>: Significant spectral changes were found in the BD region during NLMP. Transplanted livers that developed BC showed changes between 525 and 850 nm, while discarded ones had changes between 625 and 725 nm. Specific spectral bands (500-575 nm, 775-1000 nm) were linked to transplant outcomes and BC. <b>Conclusions:</b> HSI shows promise as a non-invasive tool to assess BD viability during NLMP and may help predict post-transplant BC.</p>\",\"PeriodicalId\":8874,\"journal\":{\"name\":\"Bioengineering\",\"volume\":\"12 9\",\"pages\":\"\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-09-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12467302/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioengineering\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.3390/bioengineering12090966\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12090966","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
Spectral Analysis of Extrahepatic Bile Ducts During Normothermic Liver Machine Perfusion.
Background: Biliary complications (BC) affect 5-32% of liver transplant (LT) patients and include strictures, leaks, stones, and disease recurrence. Their risk increases with extended criteria donor (ECD) livers, contributing to early graft dysfunction. Normothermic liver machine perfusion (NLMP) helps reduce bile duct (BD) damage overall, but anastomotic region issues persist. This study assessed hyperspectral imaging (HSI) as a non-invasive method to evaluate BD viability during NLMP. Methods: Eleven donor livers underwent NLMP with HSI at the start and end. Seven were transplanted; four were discarded. HSI measured tissue oxygenation, perfusion, and composition. The spectral data were analyzed using ANOVA, post hoc t-tests, and multifactorial ANOVA to assess spectral changes related to BD position, transplant status, and occurrence of BC. Results: Significant spectral changes were found in the BD region during NLMP. Transplanted livers that developed BC showed changes between 525 and 850 nm, while discarded ones had changes between 625 and 725 nm. Specific spectral bands (500-575 nm, 775-1000 nm) were linked to transplant outcomes and BC. Conclusions: HSI shows promise as a non-invasive tool to assess BD viability during NLMP and may help predict post-transplant BC.
期刊介绍:
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering